AstraZeneca gets $1B in BARDA funding to advance Covid-19 vaccine

Published on:

The drugmaker licensed the vaccine last month from the University of Oxford, which is developing it in a Phase I/II clinical trial in southern England. The company also plans a Phase III study.

Read more    Source:

Leave a Reply